Clinical Research Directory

Inclusion Criteria: Pediatric patients undergoing routine retinal surgery or laser treatment under anesthesia for a variety of visual conditions. These conditions and procedures include but are not limited to: Conditions: * Familial Exudative Vitreoretinopathy * Coats' Disease * Exudative Retinopathy * Lattice degeneration * Retinal holes * Sickler's syndrome * Retinal detachment, rhegmatogenous * Retinal detachment, exudative * Retinal detachment, tractional Procedures * Laser photocoagulation * Cryotherapy * Retinal detachment repair with scleral buckle and cryotherapy * Retinal detachment repair with vitrectomy * Written informed consent from parent/legal guardian Exclusion Criteria: Preprocedural * Active or history of chronic or recurrent inflammatory eye disease in either eye * Any patient of reproductive potential that has a positive pregnancy test during pre-procedural testing * Active or history of increased ocular pressure * Patients with active corneal, conjunctival, and canalicular infections * Patients with punctal stenosis or other punctal anatomical abnormalities that would not be conducive with device insertion * Nasolacrimal duct obstruction * Laser or incisional ocular surgery during the study period and 6 months prior in the study eye * current use of systemic or topical steroids or NSAIDS on a regular basis * History of autoimmune disease that may interfere with treatment/outcomes * Ocular pain at the time of screening * Known malignancy * Current use of cyclosporin or a TNF blocker * Ocular hypertension IOP \>25, actively taking medications for ocular hypertension, any history of IOP spikes in either including steroid associated IOP elevation * Congenital ocular lid and tear duct system abnormalities (e.g. congenital ectropion/entropion, trichiasis) * Evidence of acute external ocular infection of the study eye * Active or history of HSV * Previous trauma causing deformity * Previous enrollment or current enrollment with another clinical trial within the last 30 days that may interfere with treatment * Known allergies to product under investigation * Inability to engage in VA testing * Investigator determines that the candidate is not eligible for participation based on clinical or historical factors that would interfere with treatment or impact patient safety not specified above * Current artificial tear use \>4x daily * Current use of any topical ocular drops * Anyone who, in the opinion of the investigator, would not be a good candidate for the study. Intraoperatively * Multiple procedures required * Complication occurs that surgeon determines makes the patient ineligible for study inclusion * Unsuccessful dilation of the punctum to 0.7mm when dilation attempted * during the exam under anesthesia, if it is decided that periocular Kenalog injection is indicated this patient fails screen and will no longer be eligible for the study